Biotech · Private company · Baltimore, MD, US
Scanogen, Inc.
Track this companyFree. Adds Scanogen, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards10
- Rapid ID and AST Directly from Whole Blood Using Single Molecule DetectionFiscal year 2026 · $796.6KNIH RePORTER 5R01AI175063-04 · fetched Nov 12, 2026
- Bloodstream infection detection directly on whole bloodFiscal year 2026 · $1MNIH RePORTER 5R44AI124871-07 · fetched Nov 12, 2026
- Bloodstream infection detection directly on whole bloodFiscal year 2026 · $972.2KNIH RePORTER 5SB1AI192001-02 · fetched Nov 12, 2026
- Bloodstream infection detection directly on whole bloodFiscal year 2025 · $969.4KNIH RePORTER 1SB1AI192001-01A1 · fetched Nov 12, 2026
- Rapid ID and AST Directly from Whole Blood Using Single Molecule DetectionFiscal year 2025 · $785.4KNIH RePORTER 5R01AI175063-03 · fetched Nov 12, 2026
- Bloodstream infection detection directly on whole bloodFiscal year 2025 · $1MNIH RePORTER 5R44AI124871-06 · fetched Nov 12, 2026
- Culture and amplification-free bacterial sepsis diagnosisFiscal year 2025 · $1MNIH RePORTER 5R44AI167330-04 · fetched Nov 12, 2026
- Highly Multiplexed Single Molecule TetheringFiscal year 2025 · $999.8KNIH RePORTER 5R44AI179310-03 · fetched Nov 12, 2026
- Bloodstream infection detection directly on whole bloodFiscal year 2024 · $1MNIH RePORTER 2R44AI124871-05A1 · fetched Nov 12, 2026
- Rapid ID and AST Directly from Whole Blood Using Single Molecule DetectionFiscal year 2024 · $785.8KNIH RePORTER 5R01AI175063-02 · fetched Nov 12, 2026